iBio Expands Commercial Collaboration With Bio-Manguinhos and Fraunhofer

June 17, 2014 iBio, Inc., a leading provider of plant-based biotechnology for developing and manufacturing biological products, amended its multiproduct license and collaboration agreement with Brazil’s Bio-Manguinhos/Fiocruz and the Fraunhofer USA Center for Molecular Biotechnology to enable expansion of joint work on an iBioLaunchâ„¢-produced recombinant yellow fever vaccine and other products. Yellow fever vaccine candidates based on iBio’s proprietary technology, …